Wordt geladen...
Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians
Inhibition of epidermal growth factor receptor (EGFR) has become an important target in the treatment of advanced non-small cell lung cancer (NSCLC). Erlotinib and gefitinib, two small molecular agents that target the tyrosine kinase domain of the EGFR, were approved in many countries for the treatm...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3244201/ https://ncbi.nlm.nih.gov/pubmed/22229045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011427927 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|